Actinium Pharmaceuticals CEO Sandesh Seth's 2019 pay slips 20% to $1.1M

Actinium Pharmaceuticals reports 2019 executive compensation

By ExecPay News

Published: October 7, 2020

Actinium Pharmaceuticals reported fiscal year 2019 executive compensation information on October 7, 2020.
In 2019, four executives at Actinium Pharmaceuticals received on average a compensation package of $649K, a 11% decrease compared to previous year.
Average pay of disclosed executives at Actinium Pharmaceuticals
Sandesh Seth, Chief Executive Officer, received $1.1M in total, which decreased by 20% compared to 2018. 51% of Seth's compensation, or $561K, was in salary. Seth also received $300K in bonus and $241K in option awards.
Mark Berger, Chief Medical Officer, received a compensation package of $554K, which decreased by 9% compared to previous year. 73% of the compensation package, or $405K, was in salary.
Dale Ludwig, Chief Scientific and Technology Officer, earned $497K in 2019, a 17% increase compared to previous year.
Steve O'Loughlin, Chief Financial Officer, received $443K in 2019, which decreases by 12% compared to 2018.

Related executives

Sandesh Seth

Actinium Pharmaceuticals

Chief Executive Officer

Mark Berger

Actinium Pharmaceuticals

Chief Medical Officer

Dale Ludwig

Actinium Pharmaceuticals

Former Chief Scientific and Technology Officer

Steve O'Loughlin

Actinium Pharmaceuticals

Chief Financial Officer

You may also like

Source: SEC filing on October 7, 2020.